Biogen Idec, Inc. (BIIB) Reports Solid Q2 Results
Tweet Send to a Friend
Biogen Idec, Inc. (NASDAQ: BIIB) reported Q2 EPS of $1.82 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
